- Home
- OLP vs PLRX Comparison
OLP vs PLRX Comparison
Compare OLP & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLP | PLRX |
|---|---|---|
| Founded | 1982 | 2015 |
| Country | United States | United States |
| Employees | 9 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 502.8M | 73.7M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OLP | PLRX |
|---|---|---|
| Price | $22.65 | $1.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $26.75 | $2.67 |
| AVG Volume (30 Days) | 57.2K | ★ 352.2K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.88% | N/A |
| EPS Growth | N/A | ★ 29.97 |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $82,740,000.00 | N/A |
| Revenue This Year | $11.98 | N/A |
| Revenue Next Year | $3.71 | N/A |
| P/E Ratio | $22.99 | ★ N/A |
| Revenue Growth | ★ 1.02 | N/A |
| 52 Week Low | $19.62 | $1.02 |
| 52 Week High | $25.88 | $1.95 |
Technical Indicators
Market Signals| Indicator | OLP | PLRX |
|---|---|---|
| Relative Strength Index (RSI) | 35.05 | 52.33 |
| Support Level | $22.43 | $1.11 |
| Resistance Level | $23.63 | $1.26 |
| Average True Range (ATR) | 0.41 | 0.04 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 23.47 | 60.87 |
Price Performance
Historical ComparisonAbout OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.